Summary
"What is the problem being addressed?The current rate of failure during development for getting new drugs to cancer patients is outrageously high (around 95%). Most of these failures can be attributed to unacceptable toxicity during clinical trials or more often to lack of...
More information & hyperlinks
Web resources: | https://www.stemtektherapeutics.com/en/cell2sphere-kit |